Ying‐Li Luo

2.3k total citations · 1 hit paper
37 papers, 1.9k citations indexed

About

Ying‐Li Luo is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Ying‐Li Luo has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Biomedical Engineering and 12 papers in Immunology. Recurrent topics in Ying‐Li Luo's work include RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (11 papers) and Immunotherapy and Immune Responses (7 papers). Ying‐Li Luo is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (11 papers) and Immunotherapy and Immune Responses (7 papers). Ying‐Li Luo collaborates with scholars based in China, United States and Poland. Ying‐Li Luo's co-authors include Jun Wang, Cong‐Fei Xu, Song Shen, Xianzhu Yang, Xiao‐Jiao Du, Zhiting Cao, Zi-Dong Lu, Zhen Gu, Hongjun Li and Gui Zhao and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Ying‐Li Luo

37 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases

2024 80 citations Yi Ru, Ying‐Li Luo et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying‐Li Luo China	22	1.1k	625	440	407	256	37	1.9k
Leaf Huang United States	25	1.2k 1.1×	691 1.1×	481 1.1×	743 1.8×	313 1.2×	45	2.2k
Yixin Wang United States	19	776 0.7×	722 1.2×	462 1.1×	283 0.7×	337 1.3×	40	1.8k
Meir Goldsmith Israel	22	1.4k 1.2×	391 0.6×	462 1.1×	455 1.1×	170 0.7×	35	2.0k
Sean A. Dilliard United States	8	2.2k 2.0×	441 0.7×	422 1.0×	452 1.1×	219 0.9×	9	2.8k
Junhua Mai United States	25	1.1k 1.0×	595 1.0×	554 1.3×	472 1.2×	534 2.1×	58	2.1k
Zhiting Cao China	21	1.1k 1.0×	887 1.4×	236 0.5×	823 2.0×	290 1.1×	27	2.1k
Davoud Ahmadvand Iran	25	877 0.8×	520 0.8×	449 1.0×	475 1.2×	416 1.6×	68	1.9k
Heather H. Gustafson United States	10	896 0.8×	565 0.9×	665 1.5×	554 1.4×	322 1.3×	14	2.1k
Hao Qin China	19	810 0.7×	891 1.4×	437 1.0×	576 1.4×	404 1.6×	34	1.9k
João Conniot Portugal	15	697 0.6×	588 0.9×	425 1.0×	451 1.1×	216 0.8×	19	1.6k

Countries citing papers authored by Ying‐Li Luo

Since Specialization

Citations

This map shows the geographic impact of Ying‐Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Li Luo more than expected).

Fields of papers citing papers by Ying‐Li Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Li Luo. The network helps show where Ying‐Li Luo may publish in the future.

Co-authorship network of co-authors of Ying‐Li Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Li Luo. A scholar is included among the top collaborators of Ying‐Li Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Li Luo. Ying‐Li Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Xianyu, Xinru Zhou, Yi Ru, et al.. (2025). Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury. Free Radical Biology and Medicine. 229. 68–81. 10 indexed citations

Luo, Xianyu, Xinru Zhou, Didi Liu, et al.. (2025). Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury. Cell chemical biology. 32(7). 942–954.e5. 2 indexed citations

Zeng, Fanjun, et al.. (2024). A Novel Oncolytic Virus Formulation Based on Mesenchymal Stem Cell-Derived Vesicles for Tumor Therapy. Journal of Cancer. 16(3). 700–707. 1 indexed citations

Tong, Ying, et al.. (2024). Mesenchymal Stem Cell Membrane‐Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal–Organic Framework Nanoparticles. IET Nanobiotechnology. 2024(1). 1069307–1069307. 1 indexed citations

Ru, Yi, Ying‐Li Luo, Didi Liu, et al.. (2024). Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron. International Immunopharmacology. 135. 112318–112318. 14 indexed citations

Ru, Yi, Ying‐Li Luo, Xianyu Luo, et al.. (2024). Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Science Advances. 10(13). eadk1200–eadk1200. 80 indexed citations breakdown →

Luo, Ying‐Li, Xianyu Luo, Dongdong Li, et al.. (2024). Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy. Acta Pharmaceutica Sinica B. 15(3). 1242–1254. 4 indexed citations

Zhang, Yue, Gui Zhao, Jing Liu, et al.. (2023). Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors. Nano Today. 52. 101992–101992. 7 indexed citations

Ma, Yinchu, Ying‐Li Luo, Xinfeng Tang, et al.. (2023). Ferric iron coordinated cisplatin prodrug reprograms the immune-cold tumor microenvironment through tumor hypoxia relief for enhanced cancer photodynamic-immunotherapy. Nano Research. 16(7). 9930–9939. 4 indexed citations

10.

Huang, Yi, Yun Guo, Yan Zhou, et al.. (2023). Tivantinib alleviates inflammatory diseases by directly targeting NLRP3. iScience. 26(3). 106062–106062. 10 indexed citations

11.

Chen, Yifang, Yan Wang, Ying‐Li Luo, et al.. (2022). Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection. Pharmaceutical Research. 40(1). 145–156. 1 indexed citations

12.

Cao, Ziyang, Dongdong Li, Liang Zhao, et al.. (2022). Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery. Nature Communications. 13(1). 2038–2038. 47 indexed citations

13.

Zhao, Liang, et al.. (2020). Photo‐Enhanced CRISPR/Cas9 System Enables Robust PD‐L1 Gene Disruption in Cancer Cells and Cancer Stem‐Like Cells for Efficient Cancer Immunotherapy. Small. 16(52). e2004879–e2004879. 37 indexed citations

14.

Xu, Cong‐Fei, Guojun Chen, Ying‐Li Luo, et al.. (2019). Rational designs of in vivo CRISPR-Cas delivery systems. Advanced Drug Delivery Reviews. 168. 3–29. 151 indexed citations

15.

Zhang, Yue, Song Shen, Gui Zhao, et al.. (2019). In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance. Biomaterials. 217. 119302–119302. 77 indexed citations

16.

Wang, Jilong, Xiao‐Jiao Du, Jinxian Yang, et al.. (2018). The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles. Biomaterials. 182. 104–113. 89 indexed citations

17.

Xu, Cong‐Fei, Zi-Dong Lu, Ying‐Li Luo, et al.. (2018). Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases. Nature Communications. 9(1). 4092–4092. 169 indexed citations

18.

Shen, Song, Yue Zhang, Kaige Chen, Ying‐Li Luo, & Jun Wang. (2018). Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy. Molecular Pharmaceutics. 15(9). 3642–3653. 77 indexed citations

19.

Du, Xiao‐Jiao, Jilong Wang, Weiwei Liu, et al.. (2015). Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo. Biomaterials. 69. 1–11. 87 indexed citations

20.

Zuo, Zu-Qi, Kaige Chen, Xiaoyuan Yu, et al.. (2015). Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition. Biomaterials. 82. 48–59. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact